U.S. Markets closed

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.51-0.28 (-1.77%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.79
Open15.81
Bid15.20 x 1000
Ask15.55 x 800
Day's Range15.33 - 15.81
52 Week Range7.10 - 31.85
Volume93,552
Avg. Volume268,839
Market Cap255.011M
Beta (5Y Monthly)1.34
PE Ratio (TTM)N/A
EPS (TTM)-4.31
Earnings DateAug 10, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.86
  • DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services
    PR Newswire

    DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services

    DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services (ARMS), a Federally Qualified Health Center (FQHC) accredited by The Joint Commission and designated as a Primary Care Medical Home serving patients in Jefferson, Shelby, St. Clair, and Blount counties.

  • DRIO: Dario’s Evolving Strategic Vision
    Zacks Small Cap Research

    DRIO: Dario’s Evolving Strategic Vision

    By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Revenue Opportunities On July 12, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced the closure of three new employer client contracts derived from wayForward relationship. Average revenue per user for these contracts is expected to be in the low single digit range; however, the agreements were unexpected and provide an

  • DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe
    PR Newswire

    DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe

    DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System" during the virtual conference DTx Europe on July 14th at 5:55 a.m. EST.